Content area

Abstract

Background

National guidelines recommend that sexually active people with human immunodeficiency virus (PWH) who are men who have sex with men (MSM) be tested for hepatitis C virus (HCV) infection at least annually. Hepatitis C virus testing rates vary by race/ethnicity in the general population, but limited data are available for PWH.

Methods

We analyzed medical records data from MSM in the HIV Outpatient Study at 9 human immunodeficiency virus (HIV) clinics from January 1, 2011 through December 31, 2019. We excluded observation time after documented past or current HCV infection. We evaluated HCV antibody testing in each calendar year among HCV-seronegative MSM, and we assessed testing correlates by generalized estimating equation analyses.

Results

Of 1829 eligible MSM who were PWH, 1174 (64.2%) were non-Hispanic/Latino white (NHW), 402 (22.0%) non-Hispanic black (NHB), 187 (10.2%) Hispanic/Latino, and 66 (3.6%) of other race/ethnicity. Most were ≥40 years old (68.9%), privately insured (64.5%), with CD4 cell count/mm3 (CD4) ≥350 (77.0%), and with HIV viral load <200 copies/mL (76.9%). During 2011–2019, 1205 (65.9%) had ≥1 HCV antibody test and average annual HCV percentage tested was 30.3% (from 33.8% for NHB to 28.5% for NHW; P < .001). Multivariable factors positively associated (P < .05) with HCV testing included more recent HIV diagnosis, public insurance, lower CD4, prior chlamydia, gonorrhea, syphilis, or hepatitis B virus diagnoses, and elevated liver enzyme levels, but not race/ethnicity.

Conclusions

Although we found no disparities by race/ethnicity in HCV testing, low overall HCV testing rates indicate suboptimal uptake of recommended HCV testing among MSM in HIV care.

Details

Title
Hepatitis C Virus Testing Among Men With Human Immunodeficiency Virus Who Have Sex With Men: Temporal Trends and Racial/Ethnic Disparities
Author
Li, Jun 1 ; Armon, Carl 2 ; Palella, Frank J 3 ; Tedaldi, Ellen 4 ; Novak, Richard M 5 ; Fuhrer, Jack 6 ; Simoncini, Gina 4 ; Carlson, Kimberly 2 ; Buchacz, Kate 1 ; Durham, Marcus D; Akridge, Cheryl; Purinton, Stacey; Rayeed, Nabil; Agbobil-Nuwoaty, Selom; Chagaris, Kalliope; Battalora, Linda; Mahnken, Jonathan; Jahangir, Saira; Flaherty, Conor Daniel; Bustamante, Patricia; Hammer, John; Greenberg, Kenneth S; Widick, Barbara; Franklin, Rosa; Ward, Douglas J; Thomas, Troy; Stewart, Cheryl; Ording-Bauer, Linda; Kelly, Rita; Esteves, Jane; Tedaldi, Ellen M; Christian, Ramona A; Ruley, Faye; Beadle, Dania; Davenport, Princess; Wendrow, Andrea; Stockton Mayer; Scott, Mia; Thomas, Billie; Loraine Van Slyke; Mayer, Cynthia; Beitler, Terry; Maroney, Karen; Franklin, Denise

 Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA 
 Cerner Corporation, Kansas City, Missouri, USA 
 Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA 
 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA 
 University of Illinois College of Medicine, Chicago, Illinois, USA 
 Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA 
Publication year
2021
Publication date
Apr 2021
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171168634
Copyright
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.